English | 中文
Therapy Case
Patient's Words
Recovered Patients Club
UserName:
Password: 
 
Vital Therapies, Inc. (VTI) is developing the first human liver cell-based Extracorporeal Liver Assist Devic (ELAD.).  ELAD provides metabolic support for patients with severe liver failure by processing toxins and synthesizing proteins that are key products of normal human liver function.  The WHO identified the worldwide market for acute-on-chronic liver failure at approximately 12 million patients. In China alone there are over 400,000 deaths each year from liver disease.  VTI has completed a successful pivotal trial and filed for market approval in China ...
 Cyborg Therapy
 Doctors test latest attempt at artificial liver
 VTI Is Shipping ELAD to China (Source from: Heal...
 A New Hope for Patients of Sever Liver Failure: ...
 China’s Clinical Trial Under Way: The First Ever...
 USA MGH Liver machine rejuvenates patient
Index>> Club
Structure of “Elad recover patients Club”
Proposals on the Establishment of “ELAD Rehabilitation Friendship Association” (RFA)
"ELAD Love Care"--- Recording of Serious liver disease Sufferer Condole Activity
“ELAD Love Care” __ Recording of Serious liver disease Sufferer Condole Activity
4information in total 20/Page this1/1Page     Page
 

Vital Therapies.Inc

China Kind Fund

Vital Therapies.Inc

China Kind Fund

Vital Therapies.Inc

China Kind Fund

Vital Therapies.Inc

China Kind Fund
About us | Legal Statement | Recruitment | Contact us
Copyright : CKF Special Fund Administration Committee. Beijing CKF &VTI Medical Technology Promotion Co. Ltd.